Skip to main content
Jose Luchsinger, MD, Internal Medicine, New York, NY, NewYork-Presbyterian/Columbia University Irving Medical Center

JoseAlejandroLuchsingerMD

Internal Medicine New York, NY

Associate Professor of Medicine at NewYork-Presbyterian/Columbia University Medical Center Associate Professor of Epidemiology at CUMC

Dr. Luchsinger is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Luchsinger's full profile

Already have an account?

Education & Training

  • Columbia University Joseph P. Mailman School of Public Health
    Columbia University Joseph P. Mailman School of Public HealthMPH, Epidemiology, 1997 - 1999
  • Icahn School of Medicine at Mount Sinai/Morningside/West
    Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 1993 - 1997
  • Central University of Venezuela
    Central University of VenezuelaClass of 1991

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1996 - 2026

Awards, Honors, & Recognition

  • Community Health Award Riverstone Life Services, Riverstone Annual Gala, 2014
  • Nominated for Standing Membership National Advisory Council on Minority Health and Health Disparities, National Institute on Minority Health and Health Disparities, 2014
  • Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2011-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Reconsidering Harbingers of Dementia: Progression of Parietal Lobe White Matter Hyperintensities Predicts Alzheimer's Disease Incidence  
    Brickman AM, Zahodne LB, Guzman VA, Narkhede A, Meier IB, Griffith EY, Provenzano FA, Schupf N, Manly JJ, Stern Y, Luchsinger JA, Mayeux R, Neurobiol Aging, 1/1/2015
  • Peer-led Healthy Lifestyle Program in Supportive Housing: Study Protocol for a Randomized Controlled Trial  
    Cabassa LJ, Stefancic A, O'Hara K, El-Bassel N, Lewis-Fernandez R, Luchsinger JA, Gates L, Younge R, Wall M, Weinstein L, Palinkas LA, Trials, 1/1/2015
  • Plasma Nutrient Status of Patients with Alzheimer's Disease: Systematic Review and Meta-analysis  
    Lopes da Silva S, Vellas B, Elemans S, Luchsinger J, Kamphuis P, Yaffe K, Sijben J, Groenendijk M, Stijnen T, Alzheimers Dement, 1/1/2014
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Possible Disparate Contribution of Diabetes to Cognitive Impairment in Elderly Minorities
    Noble JM, Manly JJ, Schupf N, Mayeux R, Luchsinger JA, Neuroepidemiology, 1/1/2007
  • Diabetes and the Risk of Alzheimer's Disease and Dementia
    Luchsinger JA, Tang MX, Moroney JT, Stern Y, Shea S, Mayeux R, J Am Geriatr Soc, 1/1/2000
  • A Case of a False Positive HIV Viral Load in a Man Suspected of Primary HIV Infection
    Luchsinger JA, Hembree W, J Gen Intern Med, 1/1/1999
  • Join now to see all

Lectures

  • Effects of Chronic Metformin Use on Cognition 
    ENDO 2018: 100th Endocrine Society Annual Meeting - Chicago, Illinios - 03/18/2018
  • Hyperinsulinemia and Risk of Alzheimer's Disease 
    Gotheburg, Sweden - 1/28/2003
  • Neuropsychological Differences Related to Vascular Risk Factors in Persons with Alzheimer's Disease 
    Porto Portugal - 1/22/2005
  • Join now to see all

Other

  • Dementia in Parkinson's Disease 
    Merino JG, Luchsinger J, eMedicine: Medicine, OB/GYN, Psychiatry, and Surgery
    http://www.emedicine.com/med/topic3110.htm
    1/1/2001
  • Hispanic/Latino Perspectives 
    Webinar on Diverse Populations, Health Disparities, and Dementia, organized by Administration on Agi
    1/24/2013

Press Mentions

  • $45M Grant Funds Trial of Vitamin B1 Precursor for Cognitive Decline
    $45M Grant Funds Trial of Vitamin B1 Precursor for Cognitive DeclineJuly 14th, 2022
  • Burke Neurological Institute Receives a $45 Million NIH Grant to Study a Vitamin B1 Precursor for Treatment of Alzheimer’s Disease in Multi-Center Clinical Trial
    Burke Neurological Institute Receives a $45 Million NIH Grant to Study a Vitamin B1 Precursor for Treatment of Alzheimer’s Disease in Multi-Center Clinical TrialJuly 7th, 2022
  • Poor Disease Control Linked to Cognitive Declines in Aging T1D Patients
    Poor Disease Control Linked to Cognitive Declines in Aging T1D PatientsJune 23rd, 2021
  • Join now to see all

Grant Support

  • Columbia Center For Health Of Urban Minorities (CHUM)National Center On Minority Health And Health Disparities2009–2012
  • Northern Manhattan Initiative For Minority Involvement In Clinical TrialsNational Center On Minority Health And Health Disparities2011
  • Environmental Health Disparities Research In NocemhdNational Center On Minority Health And Health Disparities2011
  • Columbia Center For The Health Of Urban Minorities - Noma CeredNational Center On Minority Health And Health Disparities2010
  • Pilot Trial Of Metformin In Amnestic MCINational Institute On Aging2008–2010
  • Vascular Factors And Mild Cognitive Impairment And Alzheimer'S DiseaseNational Institute On Aging2004–2008
  • Vascular Factors, Amyloid Beta, And Alzheimer'S DiseaseNational Institute On Aging2002–2004

Hospital Affiliations